Thank you for your interest in the Iqirvo Pregnancy
Surveillance Program. Our website is currently under
development and will be available soon.
Report pregnancies to Ipsen Pharmaceuticals, Inc. Adverse Event reporting line at 1-855-463-5127 (US patients only) or https://www.ipsen.com/contact-us/ (all patients).